Roche’s medicine Avastin plus chemotherapy improved survival in women with advanced cervical cancer, compared to chemotherapy alone
2 June 2013 | By Roche
Results of study GOG240...
List view / Grid view
2 June 2013 | By Roche
Results of study GOG240...
1 June 2013 | By Roche
Final results from the phase III AVAglio study...
22 May 2013 | By Roche
System improves efficiency and speed of blood sample testing in medical labs...
16 May 2013 | By Roche
First results from CLL11 announced...
15 May 2013 | By Roche
Early stage data on investigational anti-PDL1 immunotherapy...
30 April 2013 | By Roche
Roche announced that the U.S. FDA has approved ACTEMRA...
26 April 2013 | By Roche
“The CHMP’s recommendation of Erivedge is encouraging news..."
23 April 2013 | By Roche
Measures aim to ensure sustained success in a fast-changing market environment...
15 April 2013 | By Roche
Roche and Ascletis have entered into a collaboration...
11 April 2013 | By Roche
Group sales increase 6% at CER1 to 11.6 billion Swiss francs...
4 April 2013 | By Roche
The Elecsys Calcitonin marker expands Roche’s portfolio for improved thyroid management
18 March 2013 | By Roche
The EMA has expanded the approval of Pegasys...
6 March 2013 | By Roche
Viral load test uses a novel dual-probe approach designed to manage patients being treated with antiviral therapies...
5 March 2013 | By Roche
Roche to inform about plans for succession in autumn 2013...
5 March 2013 | By Roche
Roche announced that the EMA has approved PERJETA (pertuzumab) for patients with previously untreated HER2-positive metastatic breast cancer (mBC)...